Login

Pharma’s reshoring sets Orange County for growth

Over 970 life science companies operate in the county, with a concentration in Irvine
CoStar Analytics
October 9, 2025 | 3:20 P.M.

A powerful combination of federal policy and changes in tax law is fueling a surge in U.S. pharmaceutical manufacturing. A growing list of companies have announced manufacturing plant developments to be built across the country, and Orange County, a hotspot for pharma and the life sciences industry, could reap some benefits.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

News | Pharma’s reshoring sets Orange County for growth